nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Methotrexate—hematologic cancer	0.304	1	CrCtD
Leucovorin—ABCC3—hematologic cancer	0.168	1	CbGaD
Leucovorin—ABCC4—Tioguanine—hematologic cancer	0.0416	0.197	CbGbCtD
Leucovorin—Raltitrexed—Methotrexate—hematologic cancer	0.04	0.2	CrCrCtD
Leucovorin—Tetrahydrofolic acid—Methotrexate—hematologic cancer	0.04	0.2	CrCrCtD
Leucovorin—Folic Acid—Methotrexate—hematologic cancer	0.04	0.2	CrCrCtD
Leucovorin—Pralatrexate—Methotrexate—hematologic cancer	0.04	0.2	CrCrCtD
Leucovorin—Pemetrexed—Methotrexate—hematologic cancer	0.04	0.2	CrCrCtD
Leucovorin—TYMS—Gemcitabine—hematologic cancer	0.0302	0.143	CbGbCtD
Leucovorin—ABCC4—Mercaptopurine—hematologic cancer	0.0173	0.0819	CbGbCtD
Leucovorin—TYMS—Methotrexate—hematologic cancer	0.0143	0.0676	CbGbCtD
Leucovorin—ABCC2—Daunorubicin—hematologic cancer	0.0133	0.0629	CbGbCtD
Leucovorin—ABCC3—Vincristine—hematologic cancer	0.0122	0.0579	CbGbCtD
Leucovorin—ABCC3—Cisplatin—hematologic cancer	0.0114	0.054	CbGbCtD
Leucovorin—ABCC3—Etoposide—hematologic cancer	0.0112	0.0531	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—hematologic cancer	0.00764	0.0362	CbGbCtD
Leucovorin—ABCC3—Methotrexate—hematologic cancer	0.0074	0.0351	CbGbCtD
Leucovorin—ABCC2—Irinotecan—hematologic cancer	0.00635	0.0301	CbGbCtD
Leucovorin—ABCC4—Methotrexate—hematologic cancer	0.00565	0.0268	CbGbCtD
Leucovorin—ABCC2—Vinblastine—hematologic cancer	0.00565	0.0268	CbGbCtD
Leucovorin—ABCC2—Vincristine—hematologic cancer	0.00555	0.0263	CbGbCtD
Leucovorin—ABCC2—Cisplatin—hematologic cancer	0.00518	0.0245	CbGbCtD
Leucovorin—ABCC2—Etoposide—hematologic cancer	0.00509	0.0241	CbGbCtD
Leucovorin—ABCC2—Dexamethasone—hematologic cancer	0.00418	0.0198	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—hematologic cancer	0.00347	0.0164	CbGbCtD
Leucovorin—ABCC2—Methotrexate—hematologic cancer	0.00336	0.0159	CbGbCtD
Leucovorin—Tetrahydrofolic acid—FTCD—hematologic cancer	0.00082	0.384	CrCbGaD
Leucovorin—TYMS—hematopoietic system—hematologic cancer	0.000805	0.0922	CbGeAlD
Leucovorin—ABCC3—hematopoietic system—hematologic cancer	0.00066	0.0756	CbGeAlD
Leucovorin—TYMS—gonad—hematologic cancer	0.000612	0.0701	CbGeAlD
Leucovorin—ABCC4—hematopoietic system—hematologic cancer	0.000545	0.0624	CbGeAlD
Leucovorin—TYMS—blood—hematologic cancer	0.000533	0.0611	CbGeAlD
Leucovorin—TYMS—bone marrow—hematologic cancer	0.000516	0.0591	CbGeAlD
Leucovorin—TYMS—lung—hematologic cancer	0.000468	0.0535	CbGeAlD
Leucovorin—TYMS—testis—hematologic cancer	0.000441	0.0505	CbGeAlD
Leucovorin—ABCC3—blood—hematologic cancer	0.000437	0.0501	CbGeAlD
Leucovorin—Pemetrexed—DCK—hematologic cancer	0.00039	0.183	CrCbGaD
Leucovorin—ABCC3—lung—hematologic cancer	0.000384	0.0439	CbGeAlD
Leucovorin—ABCC3—testis—hematologic cancer	0.000362	0.0414	CbGeAlD
Leucovorin—ABCC4—blood—hematologic cancer	0.000361	0.0413	CbGeAlD
Leucovorin—ABCC2—blood—hematologic cancer	0.00035	0.04	CbGeAlD
Leucovorin—ABCC4—bone marrow—hematologic cancer	0.000349	0.04	CbGeAlD
Leucovorin—TYMS—lymph node—hematologic cancer	0.00032	0.0366	CbGeAlD
Leucovorin—ABCC4—lung—hematologic cancer	0.000317	0.0362	CbGeAlD
Leucovorin—ABCC4—testis—hematologic cancer	0.000299	0.0342	CbGeAlD
Leucovorin—ABCC2—testis—hematologic cancer	0.000289	0.0331	CbGeAlD
Leucovorin—Tetrahydrofolic acid—MTR—hematologic cancer	0.000271	0.127	CrCbGaD
Leucovorin—ABCC3—lymph node—hematologic cancer	0.000262	0.03	CbGeAlD
Leucovorin—ABCC4—lymph node—hematologic cancer	0.000217	0.0248	CbGeAlD
Leucovorin—ABCC2—lymph node—hematologic cancer	0.00021	0.024	CbGeAlD
Leucovorin—TYMS—Nilotinib—Imatinib—hematologic cancer	0.000209	0.139	CbGdCrCtD
Leucovorin—Folic Acid—ABCC3—hematologic cancer	0.000146	0.0683	CrCbGaD
Leucovorin—TYMS—Vitamin A—Alitretinoin—hematologic cancer	0.000126	0.0837	CbGdCrCtD
Leucovorin—Methotrexate—ABCC3—hematologic cancer	9.98e-05	0.0467	CrCbGaD
Leucovorin—Tetrahydrofolic acid—MTHFR—hematologic cancer	9.25e-05	0.0433	CrCbGaD
Leucovorin—Folic Acid—MTHFR—hematologic cancer	9.25e-05	0.0433	CrCbGaD
Leucovorin—TYMS—Isotretinoin—Alitretinoin—hematologic cancer	8.8e-05	0.0585	CbGdCrCtD
Leucovorin—TYMS—Tretinoin—Alitretinoin—hematologic cancer	8.8e-05	0.0585	CbGdCrCtD
Leucovorin—TYMS—Podofilox—Teniposide—hematologic cancer	8.77e-05	0.0583	CbGdCrCtD
Leucovorin—Folic Acid—ABCG2—hematologic cancer	7.08e-05	0.0332	CrCbGaD
Leucovorin—TYMS—Menadione—Thalidomide—hematologic cancer	6.65e-05	0.0442	CbGdCrCtD
Leucovorin—Methotrexate—MTHFR—hematologic cancer	6.33e-05	0.0296	CrCbGaD
Leucovorin—TYMS—Vincristine—Vinorelbine—hematologic cancer	5.59e-05	0.0371	CbGdCrCtD
Leucovorin—TYMS—Vinorelbine—Vincristine—hematologic cancer	5.22e-05	0.0347	CbGdCrCtD
Leucovorin—TYMS—Vinorelbine—Vinblastine—hematologic cancer	5.22e-05	0.0347	CbGdCrCtD
Leucovorin—TYMS—Podofilox—Etoposide—hematologic cancer	5.22e-05	0.0347	CbGdCrCtD
Leucovorin—Methotrexate—ABCG2—hematologic cancer	4.85e-05	0.0227	CrCbGaD
Leucovorin—TYMS—Vinblastine—Vinorelbine—hematologic cancer	4.49e-05	0.0299	CbGdCrCtD
Leucovorin—TYMS—Vincristine—Vinblastine—hematologic cancer	4.46e-05	0.0297	CbGdCrCtD
Leucovorin—TYMS—Vinblastine—Vincristine—hematologic cancer	3.59e-05	0.0239	CbGdCrCtD
Leucovorin—TYMS—Azacitidine—Pentostatin—hematologic cancer	3.41e-05	0.0226	CbGdCrCtD
Leucovorin—TYMS—Azacitidine—Clofarabine—hematologic cancer	3.04e-05	0.0202	CbGdCrCtD
Leucovorin—TYMS—Azacitidine—Nelarabine—hematologic cancer	2.85e-05	0.019	CbGdCrCtD
Leucovorin—TYMS—Azacitidine—Fludarabine—hematologic cancer	2.23e-05	0.0148	CbGdCrCtD
Leucovorin—Methotrexate—ALB—hematologic cancer	2.11e-05	0.0099	CrCbGaD
Leucovorin—TYMS—Azacitidine—Cytarabine—hematologic cancer	2.1e-05	0.014	CbGdCrCtD
Leucovorin—TYMS—Azacitidine—Gemcitabine—hematologic cancer	2.1e-05	0.014	CbGdCrCtD
Leucovorin—TYMS—Azacitidine—Cladribine—hematologic cancer	2.05e-05	0.0136	CbGdCrCtD
Leucovorin—Methotrexate—ABCB1—hematologic cancer	2.02e-05	0.00945	CrCbGaD
Leucovorin—Ill-defined disorder—Prednisone—hematologic cancer	1.84e-05	0.000247	CcSEcCtD
Leucovorin—Dermatitis—Carmustine—hematologic cancer	1.84e-05	0.000247	CcSEcCtD
Leucovorin—Vomiting—Alitretinoin—hematologic cancer	1.84e-05	0.000247	CcSEcCtD
Leucovorin—Feeling abnormal—Prednisolone—hematologic cancer	1.83e-05	0.000246	CcSEcCtD
Leucovorin—Shock—Dexamethasone—hematologic cancer	1.83e-05	0.000245	CcSEcCtD
Leucovorin—Shock—Betamethasone—hematologic cancer	1.83e-05	0.000245	CcSEcCtD
Leucovorin—Dyspnoea—Triamcinolone—hematologic cancer	1.82e-05	0.000245	CcSEcCtD
Leucovorin—Rash—Alitretinoin—hematologic cancer	1.82e-05	0.000245	CcSEcCtD
Leucovorin—Dermatitis—Alitretinoin—hematologic cancer	1.82e-05	0.000244	CcSEcCtD
Leucovorin—Thrombocytopenia—Betamethasone—hematologic cancer	1.82e-05	0.000244	CcSEcCtD
Leucovorin—Thrombocytopenia—Dexamethasone—hematologic cancer	1.82e-05	0.000244	CcSEcCtD
Leucovorin—Vomiting—Ifosfamide—hematologic cancer	1.82e-05	0.000244	CcSEcCtD
Leucovorin—Hypersensitivity—Cisplatin—hematologic cancer	1.81e-05	0.000244	CcSEcCtD
Leucovorin—Diarrhoea—Gemcitabine—hematologic cancer	1.81e-05	0.000243	CcSEcCtD
Leucovorin—Nausea—Thalidomide—hematologic cancer	1.8e-05	0.000242	CcSEcCtD
Leucovorin—Dyspepsia—Triamcinolone—hematologic cancer	1.8e-05	0.000242	CcSEcCtD
Leucovorin—Rash—Ifosfamide—hematologic cancer	1.8e-05	0.000242	CcSEcCtD
Leucovorin—Dermatitis—Ifosfamide—hematologic cancer	1.8e-05	0.000242	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—hematologic cancer	1.8e-05	0.000241	CcSEcCtD
Leucovorin—Dizziness—Irinotecan—hematologic cancer	1.79e-05	0.000241	CcSEcCtD
Leucovorin—Urticaria—Etoposide—hematologic cancer	1.79e-05	0.000241	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—hematologic cancer	1.79e-05	0.00024	CcSEcCtD
Leucovorin—Malaise—Prednisone—hematologic cancer	1.79e-05	0.00024	CcSEcCtD
Leucovorin—Abdominal pain—Etoposide—hematologic cancer	1.78e-05	0.000239	CcSEcCtD
Leucovorin—Body temperature increased—Etoposide—hematologic cancer	1.78e-05	0.000239	CcSEcCtD
Leucovorin—Syncope—Prednisone—hematologic cancer	1.78e-05	0.000239	CcSEcCtD
Leucovorin—Vomiting—Vincristine—hematologic cancer	1.77e-05	0.000238	CcSEcCtD
Leucovorin—Anorexia—Dexamethasone—hematologic cancer	1.77e-05	0.000238	CcSEcCtD
Leucovorin—Anorexia—Betamethasone—hematologic cancer	1.77e-05	0.000238	CcSEcCtD
Leucovorin—Urticaria—Prednisolone—hematologic cancer	1.77e-05	0.000237	CcSEcCtD
Leucovorin—Asthenia—Cisplatin—hematologic cancer	1.77e-05	0.000237	CcSEcCtD
Leucovorin—Fatigue—Triamcinolone—hematologic cancer	1.76e-05	0.000237	CcSEcCtD
Leucovorin—Rash—Vincristine—hematologic cancer	1.76e-05	0.000236	CcSEcCtD
Leucovorin—Dermatitis—Vincristine—hematologic cancer	1.75e-05	0.000236	CcSEcCtD
Leucovorin—Loss of consciousness—Prednisone—hematologic cancer	1.74e-05	0.000234	CcSEcCtD
Leucovorin—Nausea—Carmustine—hematologic cancer	1.73e-05	0.000233	CcSEcCtD
Leucovorin—Vomiting—Irinotecan—hematologic cancer	1.72e-05	0.000232	CcSEcCtD
Leucovorin—Vomiting—Mitoxantrone—hematologic cancer	1.72e-05	0.000232	CcSEcCtD
Leucovorin—Nausea—Alitretinoin—hematologic cancer	1.72e-05	0.00023	CcSEcCtD
Leucovorin—Convulsion—Prednisone—hematologic cancer	1.72e-05	0.00023	CcSEcCtD
Leucovorin—Rash—Irinotecan—hematologic cancer	1.71e-05	0.00023	CcSEcCtD
Leucovorin—Rash—Mitoxantrone—hematologic cancer	1.71e-05	0.00023	CcSEcCtD
Leucovorin—Dermatitis—Mitoxantrone—hematologic cancer	1.71e-05	0.000229	CcSEcCtD
Leucovorin—Dermatitis—Irinotecan—hematologic cancer	1.71e-05	0.000229	CcSEcCtD
Leucovorin—Chills—Methotrexate—hematologic cancer	1.71e-05	0.000229	CcSEcCtD
Leucovorin—Nausea—Ifosfamide—hematologic cancer	1.7e-05	0.000228	CcSEcCtD
Leucovorin—Feeling abnormal—Triamcinolone—hematologic cancer	1.69e-05	0.000226	CcSEcCtD
Leucovorin—Diarrhoea—Cisplatin—hematologic cancer	1.68e-05	0.000226	CcSEcCtD
Leucovorin—Alopecia—Methotrexate—hematologic cancer	1.68e-05	0.000226	CcSEcCtD
Leucovorin—Vomiting—Gemcitabine—hematologic cancer	1.68e-05	0.000226	CcSEcCtD
Leucovorin—Discomfort—Prednisone—hematologic cancer	1.67e-05	0.000224	CcSEcCtD
Leucovorin—Rash—Gemcitabine—hematologic cancer	1.67e-05	0.000224	CcSEcCtD
Leucovorin—Dermatitis—Gemcitabine—hematologic cancer	1.66e-05	0.000223	CcSEcCtD
Leucovorin—Hypersensitivity—Etoposide—hematologic cancer	1.66e-05	0.000223	CcSEcCtD
Leucovorin—Erythema—Methotrexate—hematologic cancer	1.65e-05	0.000222	CcSEcCtD
Leucovorin—Nausea—Vincristine—hematologic cancer	1.65e-05	0.000222	CcSEcCtD
Leucovorin—Hypersensitivity—Prednisolone—hematologic cancer	1.64e-05	0.00022	CcSEcCtD
Leucovorin—Dyspepsia—Betamethasone—hematologic cancer	1.63e-05	0.000219	CcSEcCtD
Leucovorin—Dyspepsia—Dexamethasone—hematologic cancer	1.63e-05	0.000219	CcSEcCtD
Leucovorin—Urticaria—Triamcinolone—hematologic cancer	1.62e-05	0.000218	CcSEcCtD
Leucovorin—Dysgeusia—Methotrexate—hematologic cancer	1.62e-05	0.000218	CcSEcCtD
Leucovorin—Asthenia—Etoposide—hematologic cancer	1.62e-05	0.000217	CcSEcCtD
Leucovorin—Body temperature increased—Triamcinolone—hematologic cancer	1.62e-05	0.000217	CcSEcCtD
Leucovorin—Anaphylactic shock—Prednisone—hematologic cancer	1.62e-05	0.000217	CcSEcCtD
Leucovorin—Decreased appetite—Dexamethasone—hematologic cancer	1.61e-05	0.000217	CcSEcCtD
Leucovorin—Decreased appetite—Betamethasone—hematologic cancer	1.61e-05	0.000217	CcSEcCtD
Leucovorin—Nausea—Mitoxantrone—hematologic cancer	1.61e-05	0.000216	CcSEcCtD
Leucovorin—Nausea—Irinotecan—hematologic cancer	1.61e-05	0.000216	CcSEcCtD
Leucovorin—Infection—Prednisone—hematologic cancer	1.61e-05	0.000216	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.61e-05	0.000539	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—hematologic cancer	1.6e-05	0.000538	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.6e-05	0.000215	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.6e-05	0.000215	CcSEcCtD
Leucovorin—Fatigue—Betamethasone—hematologic cancer	1.6e-05	0.000215	CcSEcCtD
Leucovorin—Fatigue—Dexamethasone—hematologic cancer	1.6e-05	0.000215	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.6e-05	0.000536	CbGpPWpGaD
Leucovorin—Chills—Epirubicin—hematologic cancer	1.6e-05	0.000214	CcSEcCtD
Leucovorin—Pruritus—Etoposide—hematologic cancer	1.6e-05	0.000214	CcSEcCtD
Leucovorin—Shock—Prednisone—hematologic cancer	1.59e-05	0.000214	CcSEcCtD
Leucovorin—TYMS—Metabolism—MTAP—hematologic cancer	1.59e-05	0.000534	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.59e-05	0.000533	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—HSP90AA1—hematologic cancer	1.58e-05	0.00053	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—LCK—hematologic cancer	1.58e-05	0.00053	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.58e-05	0.000529	CbGpPWpGaD
Leucovorin—Alopecia—Epirubicin—hematologic cancer	1.57e-05	0.000211	CcSEcCtD
Leucovorin—Skin disorder—Prednisone—hematologic cancer	1.57e-05	0.000211	CcSEcCtD
Leucovorin—Nausea—Gemcitabine—hematologic cancer	1.57e-05	0.000211	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.57e-05	0.000527	CbGpPWpGaD
Leucovorin—Vomiting—Cisplatin—hematologic cancer	1.56e-05	0.00021	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.56e-05	0.000523	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.56e-05	0.000522	CbGpPWpGaD
Leucovorin—Rash—Cisplatin—hematologic cancer	1.55e-05	0.000208	CcSEcCtD
Leucovorin—Dermatitis—Cisplatin—hematologic cancer	1.55e-05	0.000208	CcSEcCtD
Leucovorin—Erythema—Epirubicin—hematologic cancer	1.55e-05	0.000208	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.55e-05	0.00052	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CDA—hematologic cancer	1.55e-05	0.000519	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—H3F3A—hematologic cancer	1.55e-05	0.000519	CbGpPWpGaD
Leucovorin—Diarrhoea—Etoposide—hematologic cancer	1.54e-05	0.000207	CcSEcCtD
Leucovorin—Anorexia—Prednisone—hematologic cancer	1.54e-05	0.000207	CcSEcCtD
Leucovorin—Ill-defined disorder—Methotrexate—hematologic cancer	1.54e-05	0.000206	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—GATA3—hematologic cancer	1.53e-05	0.000514	CbGpPWpGaD
Leucovorin—Feeling abnormal—Betamethasone—hematologic cancer	1.53e-05	0.000205	CcSEcCtD
Leucovorin—Feeling abnormal—Dexamethasone—hematologic cancer	1.53e-05	0.000205	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.53e-05	0.000513	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HSPA5—hematologic cancer	1.52e-05	0.000512	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.52e-05	0.000204	CcSEcCtD
Leucovorin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.52e-05	0.000204	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	1.52e-05	0.00051	CbGpPWpGaD
Leucovorin—Dysgeusia—Epirubicin—hematologic cancer	1.52e-05	0.000204	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.52e-05	0.000509	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.51e-05	0.000509	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND2—hematologic cancer	1.51e-05	0.000508	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.51e-05	0.000507	CbGpPWpGaD
Leucovorin—Hypersensitivity—Triamcinolone—hematologic cancer	1.51e-05	0.000202	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—PRKCZ—hematologic cancer	1.5e-05	0.000505	CbGpPWpGaD
Leucovorin—Malaise—Methotrexate—hematologic cancer	1.49e-05	0.0002	CcSEcCtD
Leucovorin—Dizziness—Etoposide—hematologic cancer	1.49e-05	0.0002	CcSEcCtD
Leucovorin—ABCC3—Metabolism—PC—hematologic cancer	1.49e-05	0.0005	CbGpPWpGaD
Leucovorin—Leukopenia—Methotrexate—hematologic cancer	1.48e-05	0.000199	CcSEcCtD
Leucovorin—Chills—Doxorubicin—hematologic cancer	1.48e-05	0.000198	CcSEcCtD
Leucovorin—Urticaria—Betamethasone—hematologic cancer	1.47e-05	0.000198	CcSEcCtD
Leucovorin—Urticaria—Dexamethasone—hematologic cancer	1.47e-05	0.000198	CcSEcCtD
Leucovorin—Dizziness—Prednisolone—hematologic cancer	1.47e-05	0.000198	CcSEcCtD
Leucovorin—Asthenia—Triamcinolone—hematologic cancer	1.47e-05	0.000197	CcSEcCtD
Leucovorin—Body temperature increased—Betamethasone—hematologic cancer	1.47e-05	0.000197	CcSEcCtD
Leucovorin—Body temperature increased—Dexamethasone—hematologic cancer	1.47e-05	0.000197	CcSEcCtD
Leucovorin—Abdominal pain—Dexamethasone—hematologic cancer	1.47e-05	0.000197	CcSEcCtD
Leucovorin—Abdominal pain—Betamethasone—hematologic cancer	1.47e-05	0.000197	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.46e-05	0.000492	CbGpPWpGaD
Leucovorin—Nausea—Cisplatin—hematologic cancer	1.46e-05	0.000196	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.46e-05	0.000491	CbGpPWpGaD
Leucovorin—Alopecia—Doxorubicin—hematologic cancer	1.45e-05	0.000195	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—JUN—hematologic cancer	1.45e-05	0.000487	CbGpPWpGaD
Leucovorin—Pruritus—Triamcinolone—hematologic cancer	1.45e-05	0.000194	CcSEcCtD
Leucovorin—ABCC3—Metabolism—SLC35B2—hematologic cancer	1.44e-05	0.000483	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GBA—hematologic cancer	1.44e-05	0.000483	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.44e-05	0.000483	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Epirubicin—hematologic cancer	1.44e-05	0.000193	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.43e-05	0.000482	CbGpPWpGaD
Leucovorin—Convulsion—Methotrexate—hematologic cancer	1.43e-05	0.000193	CcSEcCtD
Leucovorin—Vomiting—Etoposide—hematologic cancer	1.43e-05	0.000193	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—hematologic cancer	1.43e-05	0.000192	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.43e-05	0.00048	CbGpPWpGaD
Leucovorin—Dyspepsia—Prednisone—hematologic cancer	1.42e-05	0.000191	CcSEcCtD
Leucovorin—Rash—Etoposide—hematologic cancer	1.42e-05	0.000191	CcSEcCtD
Leucovorin—Dermatitis—Etoposide—hematologic cancer	1.42e-05	0.000191	CcSEcCtD
Leucovorin—TYMS—Metabolism—FHL2—hematologic cancer	1.42e-05	0.000476	CbGpPWpGaD
Leucovorin—Decreased appetite—Prednisone—hematologic cancer	1.4e-05	0.000189	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—hematologic cancer	1.4e-05	0.000188	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—PTEN—hematologic cancer	1.4e-05	0.000471	CbGpPWpGaD
Leucovorin—Rash—Prednisolone—hematologic cancer	1.4e-05	0.000188	CcSEcCtD
Leucovorin—Dermatitis—Prednisolone—hematologic cancer	1.4e-05	0.000188	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—HDAC2—hematologic cancer	1.4e-05	0.00047	CbGpPWpGaD
Leucovorin—Malaise—Epirubicin—hematologic cancer	1.4e-05	0.000188	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.39e-05	0.000468	CbGpPWpGaD
Leucovorin—Fatigue—Prednisone—hematologic cancer	1.39e-05	0.000187	CcSEcCtD
Leucovorin—Discomfort—Methotrexate—hematologic cancer	1.39e-05	0.000187	CcSEcCtD
Leucovorin—Syncope—Epirubicin—hematologic cancer	1.39e-05	0.000187	CcSEcCtD
Leucovorin—TYMS—Metabolism—AGRN—hematologic cancer	1.39e-05	0.000466	CbGpPWpGaD
Leucovorin—Leukopenia—Epirubicin—hematologic cancer	1.39e-05	0.000186	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—ITGA4—hematologic cancer	1.38e-05	0.000465	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—CD44—hematologic cancer	1.38e-05	0.000465	CbGpPWpGaD
Leucovorin—Constipation—Prednisone—hematologic cancer	1.38e-05	0.000186	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—MAPK8—hematologic cancer	1.37e-05	0.000461	CbGpPWpGaD
Leucovorin—Confusional state—Methotrexate—hematologic cancer	1.36e-05	0.000183	CcSEcCtD
Leucovorin—Loss of consciousness—Epirubicin—hematologic cancer	1.36e-05	0.000183	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—CDKN2B—hematologic cancer	1.36e-05	0.000456	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.36e-05	0.000455	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.35e-05	0.000455	CbGpPWpGaD
Leucovorin—Dizziness—Triamcinolone—hematologic cancer	1.35e-05	0.000182	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.35e-05	0.000454	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Methotrexate—hematologic cancer	1.35e-05	0.000181	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—IL3—hematologic cancer	1.35e-05	0.000453	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.34e-05	0.000451	CbGpPWpGaD
Leucovorin—Convulsion—Epirubicin—hematologic cancer	1.34e-05	0.00018	CcSEcCtD
Leucovorin—Infection—Methotrexate—hematologic cancer	1.34e-05	0.00018	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—IFNA1—hematologic cancer	1.34e-05	0.00045	CbGpPWpGaD
Leucovorin—Nausea—Etoposide—hematologic cancer	1.34e-05	0.00018	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—EP300—hematologic cancer	1.34e-05	0.000449	CbGpPWpGaD
Leucovorin—Feeling abnormal—Prednisone—hematologic cancer	1.33e-05	0.000179	CcSEcCtD
Leucovorin—Asthenia—Betamethasone—hematologic cancer	1.33e-05	0.000179	CcSEcCtD
Leucovorin—Asthenia—Dexamethasone—hematologic cancer	1.33e-05	0.000179	CcSEcCtD
Leucovorin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.33e-05	0.000179	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—PTPN1—hematologic cancer	1.33e-05	0.000446	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—ALB—hematologic cancer	1.33e-05	0.000446	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Methotrexate—hematologic cancer	1.32e-05	0.000178	CcSEcCtD
Leucovorin—Gastrointestinal pain—Prednisone—hematologic cancer	1.32e-05	0.000178	CcSEcCtD
Leucovorin—Nausea—Prednisolone—hematologic cancer	1.32e-05	0.000177	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.32e-05	0.000443	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—IDH2—hematologic cancer	1.32e-05	0.000442	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—HMMR—hematologic cancer	1.32e-05	0.000442	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—MTAP—hematologic cancer	1.31e-05	0.000442	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.31e-05	0.000441	CbGpPWpGaD
Leucovorin—Pruritus—Betamethasone—hematologic cancer	1.31e-05	0.000176	CcSEcCtD
Leucovorin—Pruritus—Dexamethasone—hematologic cancer	1.31e-05	0.000176	CcSEcCtD
Leucovorin—Skin disorder—Methotrexate—hematologic cancer	1.31e-05	0.000176	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—BIRC5—hematologic cancer	1.31e-05	0.00044	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—RASGRP1—hematologic cancer	1.31e-05	0.000439	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.3e-05	0.000438	CbGpPWpGaD
Leucovorin—Discomfort—Epirubicin—hematologic cancer	1.3e-05	0.000175	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—SYK—hematologic cancer	1.3e-05	0.000437	CbGpPWpGaD
Leucovorin—Vomiting—Triamcinolone—hematologic cancer	1.3e-05	0.000175	CcSEcCtD
Leucovorin—TYMS—Clobetasol propionate—Betamethasone—hematologic cancer	1.3e-05	0.00861	CbGdCrCtD
Leucovorin—TYMS—Clobetasol propionate—Dexamethasone—hematologic cancer	1.3e-05	0.00861	CbGdCrCtD
Leucovorin—Malaise—Doxorubicin—hematologic cancer	1.29e-05	0.000174	CcSEcCtD
Leucovorin—Rash—Triamcinolone—hematologic cancer	1.29e-05	0.000173	CcSEcCtD
Leucovorin—Dermatitis—Triamcinolone—hematologic cancer	1.29e-05	0.000173	CcSEcCtD
Leucovorin—Anorexia—Methotrexate—hematologic cancer	1.29e-05	0.000173	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—hematologic cancer	1.29e-05	0.000173	CcSEcCtD
Leucovorin—Urticaria—Prednisone—hematologic cancer	1.28e-05	0.000172	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—hematologic cancer	1.28e-05	0.000172	CcSEcCtD
Leucovorin—TYMS—Flunisolide—Betamethasone—hematologic cancer	1.28e-05	0.0085	CbGdCrCtD
Leucovorin—TYMS—Flunisolide—Dexamethasone—hematologic cancer	1.28e-05	0.0085	CbGdCrCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.28e-05	0.000429	CbGpPWpGaD
Leucovorin—Body temperature increased—Prednisone—hematologic cancer	1.28e-05	0.000172	CcSEcCtD
Leucovorin—Abdominal pain—Prednisone—hematologic cancer	1.28e-05	0.000172	CcSEcCtD
Leucovorin—Confusional state—Epirubicin—hematologic cancer	1.27e-05	0.000171	CcSEcCtD
Leucovorin—Diarrhoea—Dexamethasone—hematologic cancer	1.27e-05	0.000171	CcSEcCtD
Leucovorin—Diarrhoea—Betamethasone—hematologic cancer	1.27e-05	0.000171	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.27e-05	0.000426	CbGpPWpGaD
Leucovorin—TYMS—Clobetasol propionate—Triamcinolone—hematologic cancer	1.27e-05	0.00842	CbGdCrCtD
Leucovorin—TYMS—Triamcinolone—Betamethasone—hematologic cancer	1.27e-05	0.00842	CbGdCrCtD
Leucovorin—TYMS—Triamcinolone—Dexamethasone—hematologic cancer	1.27e-05	0.00842	CbGdCrCtD
Leucovorin—Anaphylactic shock—Epirubicin—hematologic cancer	1.26e-05	0.00017	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—hematologic cancer	1.26e-05	0.000169	CcSEcCtD
Leucovorin—Infection—Epirubicin—hematologic cancer	1.26e-05	0.000169	CcSEcCtD
Leucovorin—TYMS—Flunisolide—Triamcinolone—hematologic cancer	1.25e-05	0.00831	CbGdCrCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.25e-05	0.000419	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNA2—hematologic cancer	1.25e-05	0.000419	CbGpPWpGaD
Leucovorin—Shock—Epirubicin—hematologic cancer	1.24e-05	0.000167	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—TGFB1—hematologic cancer	1.24e-05	0.000418	CbGpPWpGaD
Leucovorin—Convulsion—Doxorubicin—hematologic cancer	1.24e-05	0.000167	CcSEcCtD
Leucovorin—TYMS—Metabolism—ARNTL—hematologic cancer	1.24e-05	0.000416	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Epirubicin—hematologic cancer	1.24e-05	0.000166	CcSEcCtD
Leucovorin—TYMS—Fluticasone Propionate—Dexamethasone—hematologic cancer	1.23e-05	0.00821	CbGdCrCtD
Leucovorin—TYMS—Fluticasone Propionate—Betamethasone—hematologic cancer	1.23e-05	0.00821	CbGdCrCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.23e-05	0.000414	CbGpPWpGaD
Leucovorin—Skin disorder—Epirubicin—hematologic cancer	1.23e-05	0.000165	CcSEcCtD
Leucovorin—Dizziness—Dexamethasone—hematologic cancer	1.23e-05	0.000165	CcSEcCtD
Leucovorin—Dizziness—Betamethasone—hematologic cancer	1.23e-05	0.000165	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—hematologic cancer	1.23e-05	0.000412	CbGpPWpGaD
Leucovorin—Nausea—Triamcinolone—hematologic cancer	1.21e-05	0.000163	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.21e-05	0.000408	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.21e-05	0.000407	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.21e-05	0.000405	CbGpPWpGaD
Leucovorin—TYMS—Fluticasone Propionate—Triamcinolone—hematologic cancer	1.21e-05	0.00802	CbGdCrCtD
Leucovorin—Discomfort—Doxorubicin—hematologic cancer	1.21e-05	0.000162	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—hematologic cancer	1.2e-05	0.000162	CcSEcCtD
Leucovorin—Dyspnoea—Methotrexate—hematologic cancer	1.2e-05	0.000162	CcSEcCtD
Leucovorin—TYMS—Metabolism—CA9—hematologic cancer	1.2e-05	0.000404	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ACP5—hematologic cancer	1.2e-05	0.000404	CbGpPWpGaD
Leucovorin—TYMS—Clobetasol propionate—Prednisone—hematologic cancer	1.2e-05	0.00799	CbGdCrCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDK2—hematologic cancer	1.2e-05	0.000403	CbGpPWpGaD
Leucovorin—Hypersensitivity—Prednisone—hematologic cancer	1.19e-05	0.00016	CcSEcCtD
Leucovorin—Dyspepsia—Methotrexate—hematologic cancer	1.19e-05	0.00016	CcSEcCtD
Leucovorin—TYMS—Metabolism—NCOR2—hematologic cancer	1.19e-05	0.000399	CbGpPWpGaD
Leucovorin—TYMS—Flunisolide—Prednisone—hematologic cancer	1.19e-05	0.00788	CbGdCrCtD
Leucovorin—Vomiting—Dexamethasone—hematologic cancer	1.18e-05	0.000158	CcSEcCtD
Leucovorin—Vomiting—Betamethasone—hematologic cancer	1.18e-05	0.000158	CcSEcCtD
Leucovorin—Confusional state—Doxorubicin—hematologic cancer	1.18e-05	0.000158	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—GRB2—hematologic cancer	1.17e-05	0.000394	CbGpPWpGaD
Leucovorin—Decreased appetite—Methotrexate—hematologic cancer	1.17e-05	0.000158	CcSEcCtD
Leucovorin—TYMS—Triamcinolone—Prednisone—hematologic cancer	1.17e-05	0.0078	CbGdCrCtD
Leucovorin—TYMS—Clobetasol propionate—Prednisolone—hematologic cancer	1.17e-05	0.0078	CbGdCrCtD
Leucovorin—ABCC3—Metabolism—FHL2—hematologic cancer	1.17e-05	0.000394	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PDGFA—hematologic cancer	1.17e-05	0.000393	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.17e-05	0.000393	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BIRC5—hematologic cancer	1.17e-05	0.000393	CbGpPWpGaD
Leucovorin—Rash—Betamethasone—hematologic cancer	1.17e-05	0.000157	CcSEcCtD
Leucovorin—Rash—Dexamethasone—hematologic cancer	1.17e-05	0.000157	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.17e-05	0.000157	CcSEcCtD
Leucovorin—Dermatitis—Betamethasone—hematologic cancer	1.17e-05	0.000157	CcSEcCtD
Leucovorin—Dermatitis—Dexamethasone—hematologic cancer	1.17e-05	0.000157	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—TGFB1—hematologic cancer	1.17e-05	0.000393	CbGpPWpGaD
Leucovorin—TYMS—Diflorasone—Dexamethasone—hematologic cancer	1.17e-05	0.00776	CbGdCrCtD
Leucovorin—TYMS—Diflorasone—Betamethasone—hematologic cancer	1.17e-05	0.00776	CbGdCrCtD
Leucovorin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.17e-05	0.000157	CcSEcCtD
Leucovorin—Fatigue—Methotrexate—hematologic cancer	1.16e-05	0.000156	CcSEcCtD
Leucovorin—Infection—Doxorubicin—hematologic cancer	1.16e-05	0.000156	CcSEcCtD
Leucovorin—Asthenia—Prednisone—hematologic cancer	1.16e-05	0.000156	CcSEcCtD
Leucovorin—TYMS—Flunisolide—Prednisolone—hematologic cancer	1.16e-05	0.0077	CbGdCrCtD
Leucovorin—Shock—Doxorubicin—hematologic cancer	1.15e-05	0.000155	CcSEcCtD
Leucovorin—ABCC3—Metabolism—AGRN—hematologic cancer	1.15e-05	0.000386	CbGpPWpGaD
Leucovorin—TYMS—Triamcinolone—Prednisolone—hematologic cancer	1.15e-05	0.00762	CbGdCrCtD
Leucovorin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.15e-05	0.000154	CcSEcCtD
Leucovorin—Pruritus—Prednisone—hematologic cancer	1.14e-05	0.000154	CcSEcCtD
Leucovorin—TYMS—Diflorasone—Triamcinolone—hematologic cancer	1.14e-05	0.00758	CbGdCrCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.14e-05	0.000383	CbGpPWpGaD
Leucovorin—Skin disorder—Doxorubicin—hematologic cancer	1.14e-05	0.000153	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.14e-05	0.000381	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TERT—hematologic cancer	1.13e-05	0.000381	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.13e-05	0.000381	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—IDH1—hematologic cancer	1.13e-05	0.00038	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.13e-05	0.00038	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—ABL1—hematologic cancer	1.13e-05	0.000379	CbGpPWpGaD
Leucovorin—Dyspnoea—Epirubicin—hematologic cancer	1.13e-05	0.000151	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.12e-05	0.000377	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—TXN—hematologic cancer	1.12e-05	0.000376	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ABCC3—hematologic cancer	1.12e-05	0.000376	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTO1—hematologic cancer	1.12e-05	0.000376	CbGpPWpGaD
Leucovorin—Anorexia—Doxorubicin—hematologic cancer	1.11e-05	0.00015	CcSEcCtD
Leucovorin—Feeling abnormal—Methotrexate—hematologic cancer	1.11e-05	0.00015	CcSEcCtD
Leucovorin—Dyspepsia—Epirubicin—hematologic cancer	1.11e-05	0.000149	CcSEcCtD
Leucovorin—Diarrhoea—Prednisone—hematologic cancer	1.11e-05	0.000149	CcSEcCtD
Leucovorin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.1e-05	0.000148	CcSEcCtD
Leucovorin—Nausea—Betamethasone—hematologic cancer	1.1e-05	0.000148	CcSEcCtD
Leucovorin—Nausea—Dexamethasone—hematologic cancer	1.1e-05	0.000148	CcSEcCtD
Leucovorin—Decreased appetite—Epirubicin—hematologic cancer	1.1e-05	0.000148	CcSEcCtD
Leucovorin—TYMS—Metabolism—SPHK1—hematologic cancer	1.1e-05	0.000368	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.09e-05	0.000147	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—hematologic cancer	1.09e-05	0.000146	CcSEcCtD
Leucovorin—ABCC3—Metabolism—HMMR—hematologic cancer	1.09e-05	0.000366	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—IDH2—hematologic cancer	1.09e-05	0.000366	CbGpPWpGaD
Leucovorin—TYMS—Diflorasone—Prednisone—hematologic cancer	1.08e-05	0.00719	CbGdCrCtD
Leucovorin—Constipation—Epirubicin—hematologic cancer	1.08e-05	0.000145	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.08e-05	0.000361	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDK2—hematologic cancer	1.07e-05	0.000361	CbGpPWpGaD
Leucovorin—Urticaria—Methotrexate—hematologic cancer	1.07e-05	0.000144	CcSEcCtD
Leucovorin—Dizziness—Prednisone—hematologic cancer	1.07e-05	0.000144	CcSEcCtD
Leucovorin—Abdominal pain—Methotrexate—hematologic cancer	1.07e-05	0.000143	CcSEcCtD
Leucovorin—Body temperature increased—Methotrexate—hematologic cancer	1.07e-05	0.000143	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—HGF—hematologic cancer	1.06e-05	0.000356	CbGpPWpGaD
Leucovorin—TYMS—Diflorasone—Prednisolone—hematologic cancer	1.06e-05	0.00702	CbGdCrCtD
Leucovorin—TYMS—Metabolism—UGT1A1—hematologic cancer	1.05e-05	0.000353	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—CSF2—hematologic cancer	1.05e-05	0.000352	CbGpPWpGaD
Leucovorin—Dyspnoea—Doxorubicin—hematologic cancer	1.04e-05	0.00014	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—hematologic cancer	1.04e-05	0.00014	CcSEcCtD
Leucovorin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.03e-05	0.000139	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.03e-05	0.000346	CbGpPWpGaD
Leucovorin—Dyspepsia—Doxorubicin—hematologic cancer	1.03e-05	0.000138	CcSEcCtD
Leucovorin—Vomiting—Prednisone—hematologic cancer	1.03e-05	0.000138	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.03e-05	0.000345	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ARNTL—hematologic cancer	1.02e-05	0.000344	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC22A1—hematologic cancer	1.02e-05	0.000344	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CRABP1—hematologic cancer	1.02e-05	0.000344	CbGpPWpGaD
Leucovorin—TYMS—Budesonide—Betamethasone—hematologic cancer	1.02e-05	0.0068	CbGdCrCtD
Leucovorin—TYMS—Budesonide—Dexamethasone—hematologic cancer	1.02e-05	0.0068	CbGdCrCtD
Leucovorin—TYMS—Cell Cycle—ATM—hematologic cancer	1.02e-05	0.000342	CbGpPWpGaD
Leucovorin—Rash—Prednisone—hematologic cancer	1.02e-05	0.000137	CcSEcCtD
Leucovorin—Dermatitis—Prednisone—hematologic cancer	1.02e-05	0.000137	CcSEcCtD
Leucovorin—Decreased appetite—Doxorubicin—hematologic cancer	1.02e-05	0.000137	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—CDK4—hematologic cancer	1.01e-05	0.000341	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—JAK1—hematologic cancer	1.01e-05	0.00034	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PRKCG—hematologic cancer	1.01e-05	0.00034	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.01e-05	0.000136	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—hematologic cancer	1.01e-05	0.000135	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.01e-05	0.000338	CbGpPWpGaD
Leucovorin—Urticaria—Epirubicin—hematologic cancer	1e-05	0.000135	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—hematologic cancer	1e-05	0.000134	CcSEcCtD
Leucovorin—TYMS—Budesonide—Triamcinolone—hematologic cancer	9.99e-06	0.00664	CbGdCrCtD
Leucovorin—Body temperature increased—Epirubicin—hematologic cancer	9.99e-06	0.000134	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—hematologic cancer	9.99e-06	0.000134	CcSEcCtD
Leucovorin—TYMS—Metabolism—ALOX5—hematologic cancer	9.98e-06	0.000335	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	9.97e-06	0.000335	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CA9—hematologic cancer	9.97e-06	0.000335	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ACP5—hematologic cancer	9.97e-06	0.000335	CbGpPWpGaD
Leucovorin—Hypersensitivity—Methotrexate—hematologic cancer	9.95e-06	0.000134	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—RB1—hematologic cancer	9.87e-06	0.000331	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—TGFB1—hematologic cancer	9.86e-06	0.000331	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NCOR2—hematologic cancer	9.84e-06	0.00033	CbGpPWpGaD
Leucovorin—Asthenia—Methotrexate—hematologic cancer	9.69e-06	0.00013	CcSEcCtD
Leucovorin—TYMS—Metabolism—NUP98—hematologic cancer	9.66e-06	0.000324	CbGpPWpGaD
Leucovorin—Feeling abnormal—Doxorubicin—hematologic cancer	9.64e-06	0.000129	CcSEcCtD
Leucovorin—Nausea—Prednisone—hematologic cancer	9.6e-06	0.000129	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—TP53—hematologic cancer	9.57e-06	0.000322	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.56e-06	0.000128	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.56e-06	0.000321	CbGpPWpGaD
Leucovorin—Pruritus—Methotrexate—hematologic cancer	9.56e-06	0.000128	CcSEcCtD
Leucovorin—TYMS—Budesonide—Prednisone—hematologic cancer	9.48e-06	0.00631	CbGdCrCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	9.46e-06	0.000318	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IL2RA—hematologic cancer	9.46e-06	0.000318	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—SRC—hematologic cancer	9.39e-06	0.000315	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ADCY7—hematologic cancer	9.38e-06	0.000315	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NCOA3—hematologic cancer	9.38e-06	0.000315	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—IDH1—hematologic cancer	9.37e-06	0.000315	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NUP214—hematologic cancer	9.31e-06	0.000313	CbGpPWpGaD
Leucovorin—Hypersensitivity—Epirubicin—hematologic cancer	9.31e-06	0.000125	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—hematologic cancer	9.29e-06	0.000125	CcSEcCtD
Leucovorin—ABCC3—Metabolism—GSTO1—hematologic cancer	9.26e-06	0.000311	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TXN—hematologic cancer	9.26e-06	0.000311	CbGpPWpGaD
Leucovorin—TYMS—Budesonide—Prednisolone—hematologic cancer	9.26e-06	0.00615	CbGdCrCtD
Leucovorin—Abdominal pain—Doxorubicin—hematologic cancer	9.25e-06	0.000124	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—hematologic cancer	9.25e-06	0.000124	CcSEcCtD
Leucovorin—Diarrhoea—Methotrexate—hematologic cancer	9.24e-06	0.000124	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	9.14e-06	0.000307	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PDGFB—hematologic cancer	9.13e-06	0.000307	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—MTR—hematologic cancer	9.12e-06	0.000306	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ABCG2—hematologic cancer	9.12e-06	0.000306	CbGpPWpGaD
Leucovorin—TYMS—Danazol—Prednisone—hematologic cancer	9.09e-06	0.00604	CbGdCrCtD
Leucovorin—Asthenia—Epirubicin—hematologic cancer	9.07e-06	0.000122	CcSEcCtD
Leucovorin—ABCC3—Metabolism—SPHK1—hematologic cancer	9.07e-06	0.000304	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ENO2—hematologic cancer	8.95e-06	0.000301	CbGpPWpGaD
Leucovorin—Pruritus—Epirubicin—hematologic cancer	8.94e-06	0.00012	CcSEcCtD
Leucovorin—Dizziness—Methotrexate—hematologic cancer	8.93e-06	0.00012	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—CDK2—hematologic cancer	8.86e-06	0.000297	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—RB1—hematologic cancer	8.83e-06	0.000296	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—IL6—hematologic cancer	8.76e-06	0.000294	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—UGT1A1—hematologic cancer	8.71e-06	0.000293	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTT1—hematologic cancer	8.68e-06	0.000291	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	8.68e-06	0.000291	CbGpPWpGaD
Leucovorin—Diarrhoea—Epirubicin—hematologic cancer	8.65e-06	0.000116	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	8.65e-06	0.00029	CbGpPWpGaD
Leucovorin—Hypersensitivity—Doxorubicin—hematologic cancer	8.62e-06	0.000116	CcSEcCtD
Leucovorin—Vomiting—Methotrexate—hematologic cancer	8.59e-06	0.000115	CcSEcCtD
Leucovorin—Rash—Methotrexate—hematologic cancer	8.52e-06	0.000114	CcSEcCtD
Leucovorin—Dermatitis—Methotrexate—hematologic cancer	8.51e-06	0.000114	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—MAPK14—hematologic cancer	8.5e-06	0.000285	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SDC1—hematologic cancer	8.48e-06	0.000285	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CRABP1—hematologic cancer	8.47e-06	0.000285	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC22A1—hematologic cancer	8.47e-06	0.000285	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.42e-06	0.000283	CbGpPWpGaD
Leucovorin—Asthenia—Doxorubicin—hematologic cancer	8.39e-06	0.000113	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	8.39e-06	0.000282	CbGpPWpGaD
Leucovorin—Dizziness—Epirubicin—hematologic cancer	8.36e-06	0.000112	CcSEcCtD
Leucovorin—Pruritus—Doxorubicin—hematologic cancer	8.27e-06	0.000111	CcSEcCtD
Leucovorin—ABCC3—Metabolism—ALOX5—hematologic cancer	8.26e-06	0.000277	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—FN1—hematologic cancer	8.23e-06	0.000277	CbGpPWpGaD
Leucovorin—Vomiting—Epirubicin—hematologic cancer	8.04e-06	0.000108	CcSEcCtD
Leucovorin—Nausea—Methotrexate—hematologic cancer	8.02e-06	0.000108	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—hematologic cancer	8e-06	0.000107	CcSEcCtD
Leucovorin—ABCC3—Metabolism—NUP98—hematologic cancer	8e-06	0.000269	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.98e-06	0.000268	CbGpPWpGaD
Leucovorin—Rash—Epirubicin—hematologic cancer	7.97e-06	0.000107	CcSEcCtD
Leucovorin—Dermatitis—Epirubicin—hematologic cancer	7.96e-06	0.000107	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—PIK3CG—hematologic cancer	7.88e-06	0.000265	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NCOA3—hematologic cancer	7.76e-06	0.000261	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ADCY7—hematologic cancer	7.76e-06	0.000261	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2A—hematologic cancer	7.76e-06	0.000261	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PTPN11—hematologic cancer	7.74e-06	0.00026	CbGpPWpGaD
Leucovorin—Dizziness—Doxorubicin—hematologic cancer	7.73e-06	0.000104	CcSEcCtD
Leucovorin—ABCC3—Metabolism—NUP214—hematologic cancer	7.71e-06	0.000259	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	7.68e-06	0.000258	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.63e-06	0.000256	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ABCG2—hematologic cancer	7.55e-06	0.000254	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—MTR—hematologic cancer	7.55e-06	0.000254	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MDM2—hematologic cancer	7.52e-06	0.000253	CbGpPWpGaD
Leucovorin—Nausea—Epirubicin—hematologic cancer	7.51e-06	0.000101	CcSEcCtD
Leucovorin—Vomiting—Doxorubicin—hematologic cancer	7.44e-06	9.99e-05	CcSEcCtD
Leucovorin—ABCC3—Metabolism—ENO2—hematologic cancer	7.41e-06	0.000249	CbGpPWpGaD
Leucovorin—Rash—Doxorubicin—hematologic cancer	7.37e-06	9.9e-05	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—hematologic cancer	7.37e-06	9.9e-05	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCND1—hematologic cancer	7.33e-06	0.000246	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—CREBBP—hematologic cancer	7.3e-06	0.000245	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CD44—hematologic cancer	7.21e-06	0.000242	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NQO1—hematologic cancer	7.21e-06	0.000242	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTT1—hematologic cancer	7.18e-06	0.000241	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	7.14e-06	0.00024	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	7.09e-06	0.000238	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.07e-06	0.000238	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SDC1—hematologic cancer	7.02e-06	0.000236	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—hematologic cancer	6.95e-06	9.33e-05	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—PIK3CD—hematologic cancer	6.93e-06	0.000233	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN1B—hematologic cancer	6.87e-06	0.000231	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—ALB—hematologic cancer	6.84e-06	0.00023	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYCS—hematologic cancer	6.82e-06	0.000229	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—HSP90AA1—hematologic cancer	6.78e-06	0.000228	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—EP300—hematologic cancer	6.75e-06	0.000227	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.73e-06	0.000226	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.71e-06	0.000225	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.62e-06	0.000222	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND1—hematologic cancer	6.55e-06	0.00022	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3R1—hematologic cancer	6.54e-06	0.00022	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—JAK2—hematologic cancer	6.36e-06	0.000213	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN1A—hematologic cancer	6.34e-06	0.000213	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.33e-06	0.000213	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.32e-06	0.000212	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ALB—hematologic cancer	6.3e-06	0.000211	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MAPK3—hematologic cancer	6.05e-06	0.000203	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CB—hematologic cancer	6.04e-06	0.000203	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—EP300—hematologic cancer	6.03e-06	0.000203	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTP1—hematologic cancer	6.02e-06	0.000202	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CD44—hematologic cancer	5.97e-06	0.000201	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NQO1—hematologic cancer	5.97e-06	0.000201	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ALB—hematologic cancer	5.92e-06	0.000199	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—hematologic cancer	5.88e-06	0.000197	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.85e-06	0.000196	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.83e-06	0.000196	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ABCB1—hematologic cancer	5.69e-06	0.000191	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYCS—hematologic cancer	5.65e-06	0.00019	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—HSP90AA1—hematologic cancer	5.61e-06	0.000189	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IL2—hematologic cancer	5.54e-06	0.000186	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTM1—hematologic cancer	5.53e-06	0.000186	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NCOR1—hematologic cancer	5.53e-06	0.000186	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MAPK3—hematologic cancer	5.41e-06	0.000182	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.33e-06	0.000179	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—hematologic cancer	5.26e-06	0.000177	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.05e-06	0.00017	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	4.99e-06	0.000168	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTP1—hematologic cancer	4.98e-06	0.000167	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—EP300—hematologic cancer	4.98e-06	0.000167	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—MTHFR—hematologic cancer	4.89e-06	0.000164	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—SRC—hematologic cancer	4.84e-06	0.000162	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.82e-06	0.000162	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ABCB1—hematologic cancer	4.71e-06	0.000158	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—VEGFA—hematologic cancer	4.71e-06	0.000158	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—NRAS—hematologic cancer	4.65e-06	0.000156	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NCOR1—hematologic cancer	4.58e-06	0.000154	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTM1—hematologic cancer	4.58e-06	0.000154	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—MAPK3—hematologic cancer	4.46e-06	0.00015	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TGFB1—hematologic cancer	4.32e-06	0.000145	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—hematologic cancer	4.32e-06	0.000145	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CG—hematologic cancer	4.1e-06	0.000138	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—MTHFR—hematologic cancer	4.04e-06	0.000136	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—hematologic cancer	4.01e-06	0.000135	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CREBBP—hematologic cancer	3.81e-06	0.000128	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CA—hematologic cancer	3.68e-06	0.000124	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CD—hematologic cancer	3.61e-06	0.000121	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.56e-06	0.00012	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ALB—hematologic cancer	3.56e-06	0.00012	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—hematologic cancer	3.56e-06	0.00012	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3R1—hematologic cancer	3.41e-06	0.000114	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HRAS—hematologic cancer	3.4e-06	0.000114	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CG—hematologic cancer	3.4e-06	0.000114	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CREBBP—hematologic cancer	3.15e-06	0.000106	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CB—hematologic cancer	3.15e-06	0.000106	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT1—hematologic cancer	3.01e-06	0.000101	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CD—hematologic cancer	2.99e-06	0.0001	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ALB—hematologic cancer	2.95e-06	9.9e-05	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3R1—hematologic cancer	2.82e-06	9.47e-05	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTEN—hematologic cancer	2.72e-06	9.13e-05	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CB—hematologic cancer	2.6e-06	8.74e-05	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—EP300—hematologic cancer	2.59e-06	8.71e-05	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTEN—hematologic cancer	2.25e-06	7.56e-05	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—EP300—hematologic cancer	2.15e-06	7.21e-05	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CA—hematologic cancer	1.92e-06	6.44e-05	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CA—hematologic cancer	1.59e-06	5.33e-05	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKT1—hematologic cancer	1.57e-06	5.26e-05	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKT1—hematologic cancer	1.3e-06	4.35e-05	CbGpPWpGaD
